Non-Small Cell Lung Cancer

The most common type of lung cancer, accounting for ~85% of cases, often driven by EGFR, ALK, or KRAS mutations.

Bu durum için ilaçlar

Adagrasib

CHEMBL4594350 · Small molecule

Phase 4

Alectinib

CHEMBL1738797 · Small molecule

Phase 4

Alectinib Hydrochloride

CHEMBL3707320 · Small molecule

Phase 4

Beta Carotene

CHEMBL1293 · Small molecule

Phase 4

Brigatinib

CHEMBL3545311 · Small molecule

Phase 4

Capmatinib Hydrochloride

CHEMBL3989937 · Small molecule

Phase 4

Cemiplimab

CHEMBL4297723 · Antibody

Phase 4

Ceritinib

CHEMBL2403108 · Small molecule

Phase 4

Crizotinib

CHEMBL601719 · Small molecule

Phase 4

Dabrafenib Mesylate

CHEMBL2105729 · Small molecule

Phase 4

Dacomitinib

CHEMBL2105719 · Small molecule

Phase 4

Dacomitinib Anhydrous

CHEMBL2110732 · Small molecule

Phase 4

Durvalumab

CHEMBL3301587 · Antibody

Phase 4

Ensartinib

CHEMBL4113131 · Small molecule

Phase 4

Etoposide

CHEMBL44657 · Small molecule

Phase 4

Fruquintinib

CHEMBL4303214 · Small molecule

Phase 4

Gefitinib

CHEMBL939 · Small molecule

Phase 4

Ipilimumab

CHEMBL1789844 · Antibody

Phase 4

Irinotecan Hydrochloride

CHEMBL3989514 · Small molecule

Phase 4

Lazertinib

CHEMBL4558324 · Small molecule

Phase 4

Lazertinib Mesylate

CHEMBL6068478 · Small molecule

Phase 4

Lorlatinib

CHEMBL3286830 · Small molecule

Phase 4

Lurbinectedin

CHEMBL4297516 · Small molecule

Phase 4

Mobocertinib

CHEMBL4650319 · Small molecule

Phase 4

Mobocertinib Succinate

CHEMBL4802239 · Small molecule

Phase 4

Necitumumab

CHEMBL1743047 · Antibody

Phase 4

Olmutinib

CHEMBL3786343 · Small molecule

Phase 4

Osimertinib

CHEMBL3353410 · Small molecule

Phase 4

Osimertinib Mesylate

CHEMBL3545063 · Small molecule

Phase 4

Pemetrexed

CHEMBL225072 · Small molecule

Phase 4

Pemetrexed Dipotassium

CHEMBL6068329 · Small molecule

Phase 4

Pemetrexed Disodium

CHEMBL2360464 · Small molecule

Phase 4

Pemetrexed Disodium Hemipentahydrate

CHEMBL6068335 · Small molecule

Phase 4

Pemetrexed Monohydrate

CHEMBL5315053 · Small molecule

Phase 4

Pemetrexed Tromethamine

CHEMBL3989962 · Small molecule

Phase 4

Plicamycin

CHEMBL1237054 · Small molecule

Phase 4

Porfimer Sodium

CHEMBL1201481 · Small molecule

Phase 4

Pralsetinib

CHEMBL4582651 · Small molecule

Phase 4

Quinacrine

CHEMBL7568 · Small molecule

Phase 4

Ramucirumab

CHEMBL1743062 · Antibody

Phase 4

Repotrectinib

CHEMBL4298138 · Small molecule

Phase 4

Sodium Fluoride F 18

CHEMBL1200744 · Small molecule

Phase 4

Sotorasib

CHEMBL4535757 · Small molecule

Phase 4

Sugemalimab

CHEMBL4594535 · Antibody

Phase 4

Talaporfin

CHEMBL2111186 · Small molecule

Phase 4

Talaporfin Sodium

CHEMBL2107806 · Small molecule

Phase 4

Talc

CHEMBL3989756 · Small molecule

Phase 4

Tarlatamab

CHEMBL5095292 · Antibody

Phase 4

Technetium Tc 99M Albumin Aggregated

CHEMBL1201522 · Protein

Phase 4

Technetium Tc 99M Nofetumomab Merpentan

CHEMBL2109287 · Antibody

Phase 4

Temoporfin

CHEMBL500576 · Small molecule

Phase 4

Tepotinib

CHEMBL3402762 · Small molecule

Phase 4

Tepotinib Hydrochloride

CHEMBL4594292 · Small molecule

Phase 4

Topotecan

CHEMBL84 · Small molecule

Phase 4

Topotecan Hydrochloride

CHEMBL1607 · Small molecule

Phase 4

Trametinib

CHEMBL2103875 · Small molecule

Phase 4

Tremelimumab

CHEMBL2108658 · Antibody

Phase 4

Trilaciclib

CHEMBL3894860 · Small molecule

Phase 4

Vinorelbine

CHEMBL553025 · Small molecule

Phase 4

Vinorelbine Tartrate

CHEMBL538943 · Small molecule

Phase 4

Zenocutuzumab

CHEMBL4298025 · Antibody

Phase 4

Related Conditions